000			02231 a2200649 4500
005			20250515042604.0
264		0	_c20061108
008			200611s 0 0 eng d
022			_a0007-1048
024	7		_a10.1111/j.1365-2141.2006.06280.x _2doi
040			_aNLM _beng _cNLM
100	1		_aBerenson, James R
245	0	0	_aEfficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study. _h[electronic resource]
260			_bBritish journal of haematology _cOct 2006
300			_a174-83 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aArsenic Trioxide
650	0	4	_aArsenicals _xadministration & dosage
650	0	4	_aAscorbic Acid _xadministration & dosage
650	0	4	_aCreatinine _xblood
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xblood
650	0	4	_aOxides _xadministration & dosage
650	0	4	_aProspective Studies
650	0	4	_aRecurrence
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
700	1		_aBoccia, Ralph
700	1		_aSiegel, David
700	1		_aBozdech, Marek
700	1		_aBessudo, Alberto
700	1		_aStadtmauer, Edward
700	1		_aTalisman Pomeroy, J
700	1		_aSteis, Ronald
700	1		_aFlam, Marshall
700	1		_aLutzky, Jose
700	1		_aJilani, Syed
700	1		_aVolk, Joseph
700	1		_aWong, Siu-Fun
700	1		_aMoss, Robert
700	1		_aPatel, Ravi
700	1		_aFerretti, Delina
700	1		_aRussell, Kit
700	1		_aLouie, Robert
700	1		_aYeh, Howard S
700	1		_aSwift, Regina A
773	0		_tBritish journal of haematology _gvol. 135 _gno. 2 _gp. 174-83
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.2006.06280.x _zAvailable from publisher's website
999			_c16587757 _d16587757